Medifast traded at $10.62 this Thursday February 19th, decreasing $0.09 or 0.84 percent since the previous trading session. Looking back, over the last four weeks, Medifast lost 8.92 percent. Over the last 12 months, its price fell by 25.89 percent. Looking ahead, we forecast Medifast to be priced at 32.99 by the end of this quarter and at 30.02 in one year, according to Trading Economics global macro models projections and analysts expectations.
Medifast, Inc. (Medifast) is a sellers of weight loss, weight management and healthy living products all based on its formulas under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The Company's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The Company's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.